Maximus (NYSE:MMS) Share Price Crosses Below Two Hundred Day Moving Average – Should You Sell?

Maximus, Inc. (NYSE:MMS – Get Free Report) shares passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $62.96 and traded as low as $61.16. Maximus shares last traded at $62.00, with a volume of 845,916 shares changing hands.

More Maximus News

Investors following MMS have been watching these news items:

  • Positive Sentiment: Fiscal Q4 adjusted earnings were $2.11 per share, above consensus estimates of roughly $1.85–$1.88 and up from $1.62 a year earlier. Revenue of $1.30 billion was in line with estimates. Maximus tops Q4 earnings estimates
  • Positive Sentiment: Management forecast fiscal 2027 revenue of $5.5 billion–$5.7 billion, above the cited $5.4 billion analyst consensus, and free cash flow of $700 million–$800 million while integrating Agile Defense. Maximus forecasts fiscal 2027 free cash flow
  • Negative Sentiment: Quarterly revenue fell 1.3% year over year, and reports noted the shares had slipped below their 200-day moving average, highlighting concerns about near-term momentum. Maximus stock breaks below its 200-day moving average

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MMS. Zacks Research upgraded Maximus from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 1st. Weiss Ratings reissued a “hold (c-)” rating on shares of Maximus in a report on Friday, November 13th. Finally, Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Saturday. Two analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Maximus presently has an average rating of “Hold”.

Get Our Latest Stock Analysis on MMS

Maximus Stock Up 1.0%

The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 8.60 and a beta of 0.57. The stock’s 50 day moving average is $60.19 and its 200 day moving average is $62.81. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings results on Thursday, November 19th. The health services provider reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.26. Maximus had a return on equity of 24.91% and a net margin of 7.07%. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same period last year, the company posted $1.62 EPS. The firm’s quarterly revenue was down 1.3% on a year-over-year basis. Maximus has set its FY 2027 guidance at 7.500-8.000 EPS. Analysts forecast that Maximus, Inc. will post 7.95 EPS for the current year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be issued a $0.33 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.32 annualized dividend and a dividend yield of 2.1%. Maximus’s dividend payout ratio is 19.50%.

Insiders Place Their Bets

In related news, insider Michelle Link sold 3,208 shares of Maximus stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $54.23, for a total transaction of $173,969.84. Following the transaction, the insider directly owned 13,881 shares of the company’s stock, valued at $752,766.63. The trade was a 18.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Maximus

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Bessemer Group Inc. grew its stake in shares of Maximus by 45.1% in the 3rd quarter. Bessemer Group Inc. now owns 515 shares of the health services provider’s stock worth $27,000 after purchasing an additional 160 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Maximus by 0.6% during the third quarter. Nisa Investment Advisors LLC now owns 31,919 shares of the health services provider’s stock valued at $1,698,000 after purchasing an additional 195 shares during the last quarter. Allworth Financial LP boosted its holdings in Maximus by 60.8% during the third quarter. Allworth Financial LP now owns 645 shares of the health services provider’s stock worth $35,000 after buying an additional 244 shares in the last quarter. Root Financial Partners LLC bought a new stake in Maximus during the third quarter worth approximately $26,000. Finally, Covestor Ltd boosted its holdings in Maximus by 33.2% during the third quarter. Covestor Ltd now owns 2,199 shares of the health services provider’s stock worth $117,000 after buying an additional 548 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

About Maximus

(Get Free Report)

Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.

Featured Stories

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.